Establishment Labs (NASDAQ:ESTA) Hits New 52-Week High - What's Next?

Key Points

• Establishment Labs hit a new 52-week high, trading as high as $92.89 and closing near $92.03, extending recent strength in the stock. The move came with modest volume of about 45,215 shares.
• Analyst sentiment remains mixed but mostly constructive: seven analysts rate the stock a Buy, while the consensus rating is Moderate Buy with a $90.43 price target. Mizuho recently raised its target to $105 and reiterated an Outperform rating.
• The company’s latest earnings showed strong revenue growth but continued losses, with EPS of -$0.45 versus expectations of -$0.35 and revenue up 44.7% year over year to $59.88 million. Insiders have also sold shares recently, while institutional investors continue to hold the majority of the stock.

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) shares reached a new 52-week high on Thursday . The company traded as high as $92.89 and last traded at $92.0310, with a volume of 45215 shares changing hands. The stock had previously closed at $90.62.

Wall Street Analyst Weigh In

ESTA has been the subject of several research reports. Weiss Ratings reissued a "sell (e+)" rating on shares of Establishment Labs in a research note on Wednesday, June 24th. BTIG Research reiterated a "buy" rating on shares of Establishment Labs in a research note on Monday. TD Cowen reissued a "buy" rating on shares of Establishment Labs in a report on Monday, June 8th. Wall Street Zen cut Establishment Labs from a "buy" rating to a "hold" rating in a report on Saturday, March 28th. Finally, Mizuho lifted their price target on Establishment Labs from $100.00 to $105.00 and gave the company an "outperform" rating in a research note on Wednesday. Seven analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Establishment Labs has an average rating of "Moderate Buy" and a consensus price target of $90.43.

Establishment Labs Stock Up 0.6%

The firm has a market capitalization of $2.68 billion, a price-to-earnings ratio of -61.18 and a beta of 1.06. The company has a debt-to-equity ratio of 16.82, a current ratio of 2.96 and a quick ratio of 1.91. The stock has a fifty day moving average of $79.33 and a two-hundred day moving average of $71.73.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.45) EPS for the quarter, missing analysts' consensus estimates of ($0.35) by ($0.10). Establishment Labs had a negative net margin of 19.05% and a negative return on equity of 218.77%. The company had revenue of $59.88 million during the quarter, compared to the consensus estimate of $57.40 million. During the same quarter last year, the firm posted ($0.70) EPS. The company's quarterly revenue was up 44.7% on a year-over-year basis. Sell-side analysts anticipate that Establishment Labs Holdings Inc. will post -1.07 earnings per share for the current year.

Insider Transactions at Establishment Labs

In other news, Director Quiros Juan Jose Chacon sold 105,000 shares of the business's stock in a transaction that occurred on Wednesday, May 6th. The shares were sold at an average price of $75.42, for a total value of $7,919,100.00. Following the transaction, the director owned 927,504 shares in the company, valued at approximately $69,952,351.68. The trade was a 10.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In the last three months, insiders have sold 255,000 shares of company stock worth $18,144,896. 9.99% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. KBC Group NV bought a new position in shares of Establishment Labs during the 1st quarter worth approximately $28,000. Quarry LP acquired a new stake in Establishment Labs in the third quarter worth $34,000. Kestra Advisory Services LLC bought a new stake in Establishment Labs in the fourth quarter valued at $47,000. Osaic Holdings Inc. increased its stake in Establishment Labs by 900.0% in the second quarter. Osaic Holdings Inc. now owns 2,000 shares of the company's stock valued at $85,000 after purchasing an additional 1,800 shares in the last quarter. Finally, MV Capital Management Inc. acquired a new position in shares of Establishment Labs during the fourth quarter valued at about $146,000. 72.91% of the stock is owned by institutional investors and hedge funds.

Establishment Labs Company Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company's proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company's flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.